Proliferative activity is disturbed in myeloproliferative neoplasms ( MPN ), myelodysplastic syndrome ( MDS ), and MDS / MPN diseases. Differences between MDS and MDS / MPN-Reference-Cited by-同舟云学术

Proliferative activity is disturbed in myeloproliferative neoplasms ( MPN ), myelodysplastic syndrome ( MDS ), and MDS / MPN diseases. Differences between MDS and MDS / MPN

Published:2020-08-28 Issue:3 Volume:100 Page:322-330
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Mestrum Stefan G. C.¹²^ORCID,Wit Norbert C. J.³,Drent Roosmarie J. M.²,Hopman Anton H. N.¹,Ramaekers Frans C. S.¹⁴,Leers Math P. G.²

Affiliation:

1. Department of Molecular Cell Biology, GROW‐School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands

2. Department of Clinical Chemistry and Hematology Zuyderland Medical Center Sittard‐Geleen The Netherlands

3. Central Diagnostic Laboratory (CDL) Maastricht University Medical Center Maastricht The Netherlands

4. Nordic‐MUbio Susteren The Netherlands

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21946

Reference26 articles.

1. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes

2. SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms